A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Clinical trial NCT07226843 · RECRUITING

Trial details

NCT number: NCT07226843
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Follicular Lymphoma

Start date: 2026-04-17
Primary completion: 2027-04-01
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.